Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Abbott Laboratories Continues to Impress with Strong Product Lineup and Increased Stock Target

December 26, 2024
Investors in Abbott Laboratories (NYSE:ABT) have seen a respectable 43% return over the last five years, according to data from Yahoo Finance. This positive performance has prompted several brokerages to set a price target of $130.71 for the company's stock, highlighting their confidence in its future growth.

The company's stock target has recently been increased, accompanied by a buy rating, due to Abbott Laboratories' strong product lineup. The company has consistently impressed investors with innovative and reliable healthcare solutions, contributing to its financial success.

For those seeking passive income opportunities, Abbott Laboratories is worth considering as a long-term investment. Its consistent performance and dividends make it an attractive option for investors looking for stability and potential growth.

To make informed decisions about the movement of Abbott Laboratories' stock, it is recommended to consult professional stock forecasters, such as Stocks Prognosis. Their expertise can provide valuable insights that can help investors make the most of their investment in Abbott Laboratories.
If you want to leave a comment, then you need Login or Register





Other data for ABT

Related data

ABTJune 5, 2025Abbott Laboratories ABT is Attracting Investor Attention: Here is What You Should Know  ~1 min.

Abbott Laboratories (ABT) has been making waves in the healthcare sector, attracting attention from investors around the globe....

ABTMarch 18, 2025Abbott Laboratories Continues to Drive Growth in the Healthcare Sector  ~2 min.

Abbott Laboratories (ABT) has emerged as a top player in the healthcare industry, making it an attractive stock for long-term investors....

ABTMarch 17, 2025Abbott Laboratories: A Leader in Healthcare Innovation  ~2 min.

Abbott Laboratories (NYSE: ABT) is a renowned healthcare company that has caught the attention of investors and industry experts alike....

ABTMarch 16, 2025Abbott Laboratories: Breaking New Ground in Healthcare Innovation  ~2 min.

Abbott Laboratories (NYSE: ABT) has been making waves in the healthcare industry with its groundbreaking innovations....

ABTMarch 15, 2025Abbott Laboratories: A Healthcare Stock With Long-Term Investment Potential  ~2 min.

Abbott Laboratories (NYSE:ABT) is a renowned healthcare company that has been delivering groundbreaking medical technologies and products for decades....

ABTFebruary 26, 2025Abbott Laboratories Continues to Deliver Strong Earnings Growth  ~2 min.

Abbott Laboratories, a leading global healthcare company, has reported steady growth in earnings over the past five years....

ABTFebruary 22, 2025Abbott Laboratories: A Rising Star in the Pharmaceutical Industry  ~2 min.

Abbott Laboratories (NYSE: ABT) has been making significant progress in the pharmaceutical industry, positioning itself as one of the best drug stocks to buy now....

ABTFebruary 21, 2025Abbott Laboratories NYSE:ABT: A Leading Drug Stock with Promising Future  ~1 min.

Abbott Laboratories, a renowned pharmaceutical company, has emerged as one of the best drug stocks to invest in....

ABTFebruary 21, 2025ABBOTT LABORATORIES Stock Hits Price Target with 16.11% Profit: QuantWave Forecast Success  ~2 min.

On December 2, 2024, QuantWave, the automated forecasting platform, issued a long signal for ABBOTT LABORATORIES stock when it was trading at 115.66 $....

ABTFebruary 20, 2025ABBOTT LABORATORIES Stock Hits Price Target Forecast with 17.28% Profit  ~2 min.

Abbott Laboratories (ABT) has recently achieved its price target forecast of 132.56 $, signaling a successful long trade with a profit of 17.28%....

ABTDecember 30, 2024Abbott Laboratories: A Leader in the Healthcare Industry  ~2 min.

Abbott Laboratories (NYSE:ABT) is well-known for its expertise in the healthcare industry....

ABTJanuary 25, 2025Abbott Laboratories Releases Impressive Q4 2024 Results and Issues Positive Financial Outlook for 2025  ~2 min.

Abbott Laboratories, a leading healthcare company, announced its fourth-quarter and full-year 2024 results today, highlighting strong performance across its business segments....

ABTDecember 1, 2024Abbott Laboratories Continues to Innovate in the Medical Field  ~2 min.

Abbott Laboratories (NYSE:ABT) is a renowned company in the healthcare industry that has been consistently delivering innovative solutions....

ABTDecember 6, 2024Returns At Abbott Laboratories NYSE:ABT Are On The Way Up  ~1 min.

Abbott Laboratories, a leading global healthcare company, has been experiencing an upward trend in its returns....

ABTJanuary 12, 2025Abbott Laboratories Reports Strong Q4 2024 Earnings  ~2 min.

Abbott Laboratories, a global healthcare company, has announced its impressive financial results for the fourth quarter of 2024....